In addition, a bioinformatic analysis of RNA and DNA sequencing data obtained from tumor samples taken from more than 10.000 patients with 31 different types of cancer indicated that a high level of PON-2 expression correlates with a worst prognosis in patients with multiple types of solid tumors. Here, PON2 is linked to neoplasm.